4
Changes in Ownership
Cullinan Therapeutics, Inc. Filed Acc 0001209191-21-051147
Director sold 2,857 shares at $29.05 ($82,996)
From the SEC's structured data for this filing
Trades in this filing
GADICKE ANSBERT · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-08-11 | Sale : show line 1 in the form | −347 | $29.05 | $10,080 | 280,921 | D |
| 2021-08-11 | Sale : show line 2 in the form | −2,510 | $29.05 | $72,916 | 7,911,377 | I |
| Open-market sales · 2,857 sh · avg $29.05 · $82,996 | ||||||
Loading xslF345X03/doc4.xml…